Merz: Pharmaceuticals Reimbursement Is Internal Matter; Warns on Currency Manipulation
German opposition leader Friedrich Merz stated that pharmaceuticals reimbursement policy is an internal German matter, while also criticizing countries that subsidize overcapacity and keep their currencies artificially low.
Friedrich Merz, leader of Germany's CDU party, addressed two economic issues in recent remarks. On pharmaceuticals, he said reimbursement decisions are an internal matter for Germany, adding that he is happy to keep the United States informed but not to cede control.
Separately, Merz took aim at nations he accuses of subsidizing overcapacity and maintaining artificially low currency valuations—a clear reference to trade tensions. His comments signal continued friction over industrial and monetary policies, particularly with major export competitors.
No further details were provided on specific countries or measures, but the statement aligns with broader EU concerns over unfair trade practices and currency manipulation.
Source: First Squawk